Astrazeneca PLC dividend history

Astrazeneca PLC paid $4.97bn in dividends in fiscal 2025. That was 48.6% of net income.

Dividends, buybacks and capital spending

FY2025 Q4 TTM

Buybacks (TTM): $521M
Dividends (TTM): $5B
Returned to shareholders: 47%; of free cash flow
Buybacks, last 3 fiscal years: $751M
Diluted share count: −0.1%; year over year
Total shareholder yield: 1.9%; dividends 1.7% + buybacks 0.2% of market value
Dividend payout ratio: 49%; of net income paid out
R&D spending: 24.2%; of revenue
Days sales outstanding: 94 days; receivables vs revenue

Dividends by fiscal year

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Astrazeneca PLC: dividends by fiscal year, annual
Fiscal year	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Dividends paid	3,486	3,561	3,519	3,484	3,592	3,572	3,856	4,364	4,481	4,629	4,971
Share buybacks	—	—	—	—	—	—	149	—	—	81	521
Dividends ÷ net income	123.4%	101.8%	117.3%	161.7%	269.1%	111.8%	>999%	132.7%	75.2%	65.8%	48.6%
Dividends ÷ free cash flow	174.6%	131.9%	156.3%	221.2%	180.5%	93.1%	79.1%	50.1%	49.9%	46.6%	42.3%

Dividend per share is the amount declared for the fiscal year as stated in the company's filings (including any special dividend), restated for stock splits and checked against the cash dividends paid. Dividends paid and buybacks are cash amounts; the last-twelve-months column can include an extra payment when a quarter-end date moves.

Compare with peers

Head to head: AZN vs PFE AZN vs MRK AZN vs BMY AZN vs NVO

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Astrazeneca PLC's SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Astrazeneca PLC.